NewsMV
Oracle (ORCL) is in focus after Larry Ellison reversed a plan to sell up to 50 million shares by the end of October.
The cancellation arrived one day after a regulatory filing made the intention public, pulling a $7.5 billion transaction off the table before any shares reached the market.
For positioning readers, the sequence matters more than the headline alone. A secondary sale of that size, once disclosed, introduces supply expectations against the float the moment the filing lands.
The cancellation clears that anticipated overhang, but without the resolution that actual execution would have provided.
Keep reading